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Abstract 
Osteoporosis is a common disease characterised by reduced bone mass and an increased risk 
of fragility fractures. Low bone mineral density is known to significantly increase the risk of 
osteoporotic fractures, however, the majority of non-traumatic fractures occur in individuals 
with a bone mineral density too high to be classified as osteoporotic. Therefore, there is an 
urgent need to investigate aspects of bone health, other than bone mass, that can predict the 
risk of fracture. Here, we successfully predicted association between bone collagen and nail 
keratin in relation to bone loss due to oestrogen deficiency using Raman spectroscopy. 
Raman signal signature successfully discriminated between ovariectomised rats and their 
sham controls with a high degree of accuracy for the bone (sensitivity 89%, specificity 91%) 
and claw tissue (sensitivity 89%, specificity 82%). When tested in an independent set of claw 
samples the classifier gave 92% sensitivity and 85% specificity. Comparison of the spectral 
changes occurring in the bone tissue with the changes occurring in the keratin showed a 
number of common features that could be attributed to common changes in the structure of 
bone collagen and claw keratin. This study established that systemic oestrogen deficiency 
mediates parallel structural changes in both the claw (primarily keratin) and bone proteins 
(primarily collagen). This strengthens the hypothesis that nail keratin can act as a surrogate 
marker of bone protein status where systemic processes induce changes. 
 
KEYWORDS: Raman Spectroscopy, bone, collagen, keratin, osteoporosis, microCT. 
 
Abbreviations 
AUC: Area Under the Curve (for receiver operator characteristics) 
BMD: Bone Mineral Density 
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BV/TV: Bone Volume / Total Volume (also known as bone volume density) 
DXA: Dual energy X-ray Absorptiometry 
LDA: Linear Discriminant Analysis 
microCT: micro Computed Tomography 
OVX: Ovariectomised 
PCA: Principal Component Analysis 
ROI: Region Of Interest 
SVD: Singular Value Decomposition 
1 Introduction 
Postmenopausal osteoporosis is a common disease characterised by reduced bone mass and 
an increased risk of fragility fractures which increases dramatically in incidence with age [1]. 
The risk of osteoporosis is determined by a balance between levels of peak bone mass 
attained during skeletal growth and the amount of bone that is lost later on in life [2–5].  At 
menopause, declining oestrogen levels trigger an increase in bone remodelling with 
uncoupling of osteoclastic bone resorption from osteoblastic bone formation [6]. Evidence 
from rodent and nonhuman primate studies indicates that enhanced bone remodelling 
associated with deficiency in sex hormone leads to bone loss [7–10] (in humans this type of 
change increases risk of fragility fractures).  
The majority of osteoporotic fractures occur in patients with low bone mineral density 
(BMD), as assessed by Dual energy X-ray Absorptiometry (DXA) [11–13]. However, there is 
overlap in BMD between individuals with recurrent fractures and those who have not, 
inferring that low BMD is not the only cause of fragile bones [10,14]. Degree of 
mineralization is another standard by which osteoporosis is diagnosed, however it is often 
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unreliable in detecting bone fragility. This is mainly due to its inability to take into account, 
amongst other factors [15], changes in the bone matrix protein, primarily collagen. Studies 
have shown that collagen in osteotropic patients exhibits a different structure to normal 
collagen [16,17], and have found a correlation between these structural changes in collagen 
and bone fracture [18,19].  
Ovariectomy in large rodents is a reproducible and widely accepted model of oestrogen 
deficiency and reflects many changes observed in post menopausal women. For example, it 
leads to reduction in trabecular bone volume coupled with an increase in adipose tissues (in 
some rodents), phenotypes similar to those observed in aged human. Notwithstanding this the 
model does not account for factors such as genetic variability, life style, diet and other 
hormone levels that affect bone health. A key feature of this model is that the hormone 
deficiency is a systemic effect and as such would be expected to expose the whole body of 
the animal to the same risk factor. Raman spectroscopy is a sensitive and non-invasive optical 
technique in which the transfer of energy from light to matter gives ‘fingerprint’ information 
of a sample’s chemical composition and physical state. The technique is commonly used in 
chemical analysis e.g. in forensic, and pharmaceutical science, however more recently it has 
been identified as a potential tool for evaluating bone. Using Raman spectroscopy, a 
comparison study of iliac crest biopsies and femoral head samples revealed that osteoporotic 
women with fractures had a greater carbonate/phosphate ratio in cortical bone and a higher 
carbonate/amide I ratio in femoral trabecular bone when compared to healthy women [20]. 
Other studies by Pillay et al, Towler et al. and Moran et al. used Raman spectroscopy to 
demonstrate that nails from osteoporotic patients had lower disulphide bonding compared to 
healthy controls [21–23]. A subsequent clinical study on 633 nail donors showed that Raman 
analysis of the fingernails was capable of discriminating between donors who had and who 
had not suffered a fragility fracture[24]. Detailed spectroscopic investigation revealed that the 
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structural integrity of the keratin in the nail was different between the groups, with the 
fracture group exhibiting a more disordered protein structure than the non-fracture group 
[25]. Together, these findings led to the hypothesis that changes in composition and structure 
of keratin (nail) in osteoporotic models may act as a surrogate marker of systemic processes 
that affect the structural proteins in the bone matrix (collagen).  
In this study, we further tested this hypothesis by comparing the changes in claw keratin 
Raman spectra with the changes in the proteins, chemical composition and architectural 
changes due to oestrogen deficiency in rats. The hypothesis that we are testing is that 
systemic changes that affect bone proteins may also have a parallel impact on keratin proteins 
in claws. 
 
2 Materials and Methods 
2.1 Animal experiments 
 
All animal experiments were approved by the Animal Welfare and Ethical Review Body of 
the University of Edinburgh (Scotland, UK) and conducted in accordance with the UK 
Animals (Scientific Procedures) Act 1986. Animals were housed under standard conditions of 
temperature (25 ± 1°C) and relative humidity (60 ± 10%) on 12 hours light/dark cycle with 
ad libitum access to standard pellet diet and tap water.  
2.1.1 Ovariectomy and hormone replacement  
Ovariectomy or sham ovariectomy was performed in 12 weeks old Sprague-Dawley rats as 
previously described [26]. The experiment terminated on day 77 and bone mineral density 
was measured at the tibial metaphysis by micro computed tomography (microCT).  
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2.1.2 Animal study design 
2.1.2.1 Sprague-Dawley study design and treatments 
The Sprague-Dawley study was designed and carried out at the University of Edinburgh 
(Scotland, UK). The rats were randomly assigned to 1 of 3 groups: ovariectomy (OVX, 
n=10), sham-operated (n=10) or naïve group (n=9). All rats were sacrificed at 23 weeks of 
age and bone samples (right femur) were collected and stored at -20°C. Claw samples (right 
and left claw) were collected and stored at 4°C. 
2.1.2.2 Wistar study design and treatments 
The Wistar study was developed by the Royal College of Surgeons in Ireland (RCSI, Dublin, 
Ireland). This study details the analysis of the claw samples using Raman spectroscopy 
carried out at Queen’s University Belfast. Under the terms of agreement bone samples were 
not made available. A total of 65 retired breeder Wistar rats were randomly assigned to 1 of 
11 groups including those that underwent surgical intervention and age-matched controls 
(Table 1). After completion of surgical intervention, the claw samples (right front and hind 
claws and left front and hind claws – 4 claws from each specimen) were collected and stored 
at 4°C. 
2.2 Micro-computed tomography  
Bone architecture was assessed using Micro-computed tomography (microCT) at the 
University of Edinburgh (Scotland, UK). Trabecular and cortical bone parameters were 
analysed as previously describe by Campbell & Sophocleous [27], using a Skyscan 1172 
instrument (Brucker, Belgium) set at 70kV and 142μA and at a resolution of 10μm.  Images 
were then reconstructed by the Skyscan NRecon program and analyzed using Skyscan CTAn 
software. Analysis of trabecular bone at the left distal femoral metaphysis focused on a region 
of interest (ROI) extending 1 mm proximally from the proximal tip of the primary spongiosa. 
The ROI was selected adjacent to the endocortical surface using a freehand drawing tool at 
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five to seven different levels. Auto-interpolation between these levels produced the total ROI 
for all frames selected. 
2.3 Raman spectroscopy spectra  
The bones and claws were assessed using Raman spectroscopy at Queen’s University Belfast 
(Belfast, UK). No further sample preparation was carried out. 
2.3.1 Sample analysis  
Raman spectra were recorded in a grid pattern on bone and claw samples using a 160mW 
Avalon Instrument RamanStation R1 (Avalon Instruments, Belfast, UK) at excitation 
wavelength 785 nm with a spectral resolution <4 cm-1. The samples were exposed to the laser 
beam for 18 seconds for the bones (cortical region) and 15 seconds for the claws with 0.25 
mm distance between the laser points (laser spot size 0.05 mm). A total of 196 and 45 spectra 
were collected in a grid pattern on each bone and claw sample, respectively. As the protein 
concentration is much lower in bone than the claw, the bone measurements were completed 
in triplicate. The analyst was blinded to sample treatments throughout data acquisition and 
data processing.  
2.3.2 Spectral Data analysis 
The acquired Raman data was processed using Matlab 2013a (Mathworks, Cambridge UK) 
and Labspec 6 (Horiba UK Ltd, Stanmore, UK) software. Cosmic rays were manually 
corrected by comparing each spectrum in the dataset with the spectra adjacent to it and 
identifying any sharp features (<3 pixels, >3x SNR) that occurred in only one spectrum. The 
data from the Sprague-Dawley animals were used to develop models for processing and 
analysing the Raman spectra. This included building a baseline correction model using SVD-
based background correction [28,29]. All the spectra were truncated to remove peak-less 
regions, intensity normalised (mean intensity of spectrum), mean centred and analysed using 
principle component analysis (PCA) as previously described[24]. The PCA scores for 
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components which exhibited a significant difference between the baseline and ovariectomised 
groups were put into a linear discriminant analysis, along with the normalised mean centred 
Raman data. The resulting discriminant scores were used to calculate sensitivity, specificity 
and area under the curve (AUC) performance characteristics. The processing algorithms and 
linear discriminant analysis (LDA) model developed on the claw data acquired from the 
Sprague-Dawley animals was tested on the data acquired from the Wistar rat claws to 
determine the transferability of the model to new samples and new populations. The Wistar 
group was used as a validation set, with sensitivity, specificity and AUC calculated for 
comparison with the Sprague-Dawley animals. The same processing algorithms and LDA 
model was applied to the sham ovariectomy within the Sprague-Dawley set to determine its 
impact on collagen and keratin. To obtain partial subtraction average normalized bone and 
claw spectra for detailed evaluation, the average spectrum from each group was normalised to 
the mean intensity of the Sprague-Dawley bone or claw spectra, then partially subtracted 
from the sum of all the bone or claw spectra until just before any negative features appeared 
in the result.  
2.4 Sample size calculation 
The sample size for the ovariectomy experiments was chosen to provide at least 80% power 
to detect a 1.8 standard difference (i.e. an effect size of ~1.8) in different micro-CT based 
variables between baseline, sham-operated and OVX groups. Post hoc (retrospective) power 
analyses showed that the effect size achieved for BV/TV was more than double 
(approximately 4) and the achieved power for detecting a difference in BV/TV between 
sham-operated and OVX groups was 100%. 
2.5 Micro-CT Statistical analysis  
Statistical analyses were performed using IBM (Armonk,NY) SPSS Statistics, version 19. 
Significant differences between groups (baseline, sham-operated and OVX) were assessed 
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using one-way analysis of variance (ANOVA) followed by Tukey HSD post hoc test. Power 
calculations were performed using G*Power software, version 3.1.9.2 (Heinrich Heine 
University Düsseldorf, Germany) 
3 Results  
3.1 Effects of ovariectomy on body and uterine weight  
Body weight is an important determinant of bone mass and oestrogen deficiency is often 
associated with a significant increase in body weight [30]. As shown in Figure 1A, body 
weight significantly increased in Sprague-Dawley after ovariectomy. In contrast, uterine 
weight fell significantly after ovariectomy (data not shown), indicative of the successful 
removal of ovaries. 
3.2 Effects of ovariectomy on bone architecture  
Detailed microCT analysis confirmed that ovariectomised rats had significantly lower 
trabecular bone volume (Figure 1B) and this was accompanied by a significant reduction in 
trabecular number (Figure 1C). Ovariectomy also caused a significant increase in trabecular 
separation (Figure 1D) and a decrease in trabecular connectivity, indicated by the increased 
trabecular patter factor (Figure 1E). No significant changes were observed in trabecular 
thickness after ovariectomy (Figure 1F).  Figure 1 (panel G) shows representative microCT 
images from the trabecular bone of the distal femoral metaphysis of Baseline (day zero), 
ovariectomised (OVX) and sham-operated Sprague-Dawley rats. 
3.3 Raman spectrum of bone and claw tissue compared to standards 
The average Raman spectra for Sprague-Dawley bone samples were compared to the 
corresponding claw samples from the same model shown in Figure 2A (I & III). For 
comparison, hydroxyapatite mineral, collagen and keratin standard were also included 
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(Figure 2A II, IV &V respectively). A summary of the main peaks, their wavenumber shifts, 
band assignments and whether they are due to mineral, collagen or keratin are listed in Table 
2. The Raman spectrum of bone is dominated by phosphate bands similar to those of the 
hydroxyapatite at the lower wavenumber, while at higher wavenumber the spectrum is 
comprised primarily of protein-like features. Collagen can be distinguished from keratin by 
the presence of a strong peak due to hydroxyproline (no.7) and the absence of a distinct band 
for tyrosine and tryptophan peak (no. 21). Despite the mineral peaks in close proximity, the 
hydroxyproline peaks are identifiable in the bone spectrum, while there is no evidence of the 
tyrosine and tryptophan peak (no. 21).  
3.4 Evaluation of spectral differences between bone and claw treatment groups 
To evaluate what impact ovariectomy is having on the structure of the bone and claw 
compared to their respective baseline and sham OVX treatment groups, detailed analysis of 
the spectra was performed. The spectra of the bone and claw were scaled to the mean 
intensity of the spectrum for subtraction and the subtraction spectra are presented for 
comparison in Figures 2B and C. The bone spectra show sham and OVX treatment groups 
have an elevated band at peak no. 12, which is indicative of carbonate deposition within the 
hydroxyapatite matrix. Comparison between baseline, sham-OVX and OVX clearly indicates 
OVX treatment affects both the mineral and collagen matrix phases of the bone. OVX 
decreased the mineral bands indicated by the peaks at lower Raman shift at peak no. 1 and 3, 
and increased collagen bands, indicated by stronger peaks at Raman shifts at peak no. 20 and 
22-24 compared to control. In the claw Raman signatures, changes to keratin secondary 
structure were observed; compared to baseline, OVX reduced β-sheet content (peak no. 24) 
and resulted in an altered α-helical conformation (peak shift from peak no. 22 in baseline to 
peak no. 23 in OVX group). Interestingly, the Raman spectral signatures for the bone and 
claw sham-OVX groups indicate sham OVX is subtly altering the structure of proteins in 
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both tissues, but at a much lower rate than the OVX. The bone sham-OVX spectra showed a 
reduction in the overall protein content (peak no. 13-24) compared to baseline. 
3.5 Discrimination between healthy and osteoporotic tissue using a LDA model 
In this study, using the data acquired from bone and claw spectra from an osteoporotic model, 
an LDA model was created in an attempt to discriminate between healthy and osteoporotic 
bone and claw tissue. Figure 2 (panel D) shows the Sprague-Dawley bone discriminant 
function (i) calculated from the LDA modelled on OVX against baseline group, and for 
comparison the Sprague-Dawley claw discriminant function (ii) calculated from the LDA 
modelled on the same treatment groups. The discriminant function highlights the variance 
between the treatment groups in both tissues. The prominent positive features are 
representative of the baseline (healthy state), whilst the prominent negative features illustrate 
the changes in the tissues induced by ovariectomy (osteoporotic state). The prominent 
positive peaks in the mineral phase of the bone discriminant function (left side of dotted line) 
include phosphate peaks, no. 1, 3 and 9 in the positive direction, while the carbonate peak 
(no.12) is a prominent negative peak. For comparison between the protein content of both 
tissues, the positive and negative peaks in the region right of the dotted line are highlighted. 
The prominent negative peaks shown in the bone collagen region of the discriminant function 
include C-H bone peaks (no 18 and 20) and amide I random coil peak (no. 23), and these 
same peaks were negative in the claw keratin discriminant function. Furthermore, the main 
positive peaks in the claw discriminant function, including amide I α-helix and β-sheet peaks 
(no. 22 and 24 respectively), were also local maxima in the bone discriminant function. The 
fact that these local areas of variance, from two different tissues, were the same suggests that 
ovariectomy is altering the structure of collagen and keratin in a similar manner. 
Figure 3A shows the Sprague-Dawley bone sample LDA results modelled on the OVX group 
against baseline group and projected onto the sham OVX treatment group. The LDA 
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classified the baseline group as significantly different compared to OVX, whilst the sham 
OVX group was classified as not significantly different. Moreover, the OVX group was 
significantly different to the baseline and sham OVX groups. To give an indication of how 
appropriate this model is for determining differences and similarities in bone from health and 
osteoporotic rat tissue using Raman spectra, the sensitivity, specificity and AUC values were 
calculated from the derived LDA (Table 3); this model gave 89% sensitivity, 91% specificity 
and an area under the curve (AUC) of 94%.  
The claws showed similar levels of performance to the bone tissue. The LDA for the 
Sprague-Dawley rat claws (Figure 3B) classified the baseline group as significantly different 
compared to all of the other treatment groups, with OVX being the most significant, while 
OVX is significantly different from baseline and sham OVX. The Wistar rats showed no 
significant difference between the control and ovariectomised rats at the early stages of 
treatment (≤8 weeks), but after the 12 week delay the ovariectomised rats had a significantly 
lower score than the control rats and also than the rats sacrificed at a younger age (Figure 
3C). The Sprague-Dawley calibration set yielded a model with a sensitivity of 89% and a 
sensitivity of 82%, and AUC of 92%.  The Wistar rat data used as validation of the model 
achieved a sensitivity of 92% and a specificity of 85%, while the AUC was 94%.  
4 Discussion 
Ageing is associated with many degenerative processes, including the weakening of bone, 
leading (in humans) to increased susceptibility to fracture, even in the absence of significant 
trauma. The rat ovariectomy model is a standard model to study postmenopausal osteoporosis 
in pre-clinical trials [31]. Ovariectomised rats display similar stages of osteoporosis as in 
humans [32], and the model allows for investigation of changes occurring against a more 
uniform population, using younger animals (minimising effect of different rates of ageing) in 
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a highly controlled environment. A key difference is that the rat models do not tend to sustain 
fragility fractures as a result of the deterioration in bone health. In this study, we analysed the 
impact of ovariectomy on bone collagen and claw keratin protein structure in ovariectomised 
rats using Raman spectroscopy.  
Although we acknowledge that the ovariectomy model dose not fully capture all of the 
complexities postmenopausal osteoporosis, it is widely used to explore mechanisms of bone 
loss and to investigate the effects of treatments for osteoporosis.  In this study we have used 
this model to analyse the impact of ovariectomy on bone collagen and claw keratin protein 
structure using Raman spectroscopy. Collagen and keratin have similar structures and 
properties [33], and in this study we showed that these proteins have similar Raman 
signatures in the mineral-free region.  
Formation of collagen fibres in bone involves a series of complex post-translational 
modifications including hydroxylation of proline and lysine, glycosylation of hydroxylysine 
and generation of collagen crosslinks that are often associated with bone maturation [34]. 
Due to the interrelationship with mineralization, it would be expected that any change to 
collagen structure could alter collagen fibre organization and orientation and thus the mineral 
to collagen ratio, all of which help regulate bone strength, flexibility and fragility [34]. 
Previous studies have indicated that oestrogen deficiency leads to an increased turnover of 
the bone collagen matrix with an imbalance in favour of resorption over formation [34]. This 
increased rate of collagen synthesis generates abnormalities in post-translational 
modifications in collagen, including over-hydroxylation of lysine residues and over-
glycosylation of hydroxylysine, leading to weakened collagen fibres with fewer crosslinks 
that affects mineralization of the fibre [35]. Using Raman spectroscopy, we showed that 
ovariectomy in adult rats decreased mineral to collagen ratio compared to baseline. This 
result agrees with previous findings [32,36] and that shows ovariectomy increases the protein 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
16 
 
content relative to the mineral content in the bone spectra. Raman spectra of bone in humans 
exhibit changes in protein content relative to mineral content across a number of bone 
pathologies including osteoporosis and osteogenesis imperfecta [37–39].  
Keratin is a key structural protein that provides cells and tissues with resilience to withstand 
mechanical and chemical stress [40–43]. Previous structural Raman spectroscopy analysis 
revealed Keratin’s resilience to be due to its highly ordered structure, mostly in the α-helical 
conformation, with a high degree of protein folding and disulphide bond formation [44]. 
Thus, similar to collagen, keratin’s properties most likely depend on coherent organisation 
and disruption of the secondary or tertiary structure of the protein would impact its ability to 
perform its functions. Indeed, studies by Farran et al. show fingernails’ mechanical properties 
change under different conditions and this was hypothesised to occur via altered matrix 
flexibility caused by breakdown of disulphide bonding [45]. Evaluation of the claw Raman 
spectral information in this study showed substantial changes to the secondary and tertiary 
structure of claw keratin upon ovariectomy. The position of the amide bands for α-helices is 
sensitive to the tertiary structure, with α-helices in globular proteins giving amide I bands at a 
higher wavenumber position than α-helices in fibrous proteins. Upon ovariectomy the Raman 
band corresponding to α-helices is shifted to a higher position reflecting a change in tertiary 
structure that suggests ovariectomy is associated with a reduction in fibrous structure and an 
increase in globular structure. The tertiary structure of collagen is also being altered by 
ovariectomy in a similar manner. Compared to baseline, ovariectomy shows an increase in 
amide I collagen content, particularly in the globular structure as signified by a large increase 
in amide I peak at a higher wavenumber position indicative of random structure (peak no. 
24). Similar changes (elevated intensity around 1660 cm-1 and reduced intensity at 1685 cm-1) 
in the amide I region from collagen of bone for ovariectomised rats has been reported by 
Orkoula et al [46]. Keratin in claws and nails is arranged in closely fitting fibrous strands. In 
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this study, our data suggest that the rigid order to claw keratin fibres in ovariectomised rats 
was disrupted leading to a less organized keratin structure with more flexibility. Whilst these 
keratin changes are occurring upon ovariectomy, our results also suggest bone collagen 
structure is becoming less organised, which may impact on the organization and orientation 
of collagen fibres and thus affect mineral deposition; all of which are important in the 
maintenance of bone strength, toughness and fragility. 
The model algorithm generated in this study was able to significantly distinguish the baseline 
and sham-ovariectomised groups from the ovariectomised group in bone and claw tissues. It 
should be noted that the animals that underwent sham-ovariectomy did show altered Raman 
signatures compared to both baseline and ovariectomy, but these changes are independent of 
those associated with the true ovariectomy as the LDA models did not classify the sham as 
significantly different to baseline. As control animals were not sacrificed at the later age it is 
not possible to identify if the changes in the sham ovariectomy are a result of natural aging 
compared to the baseline animals or if it could be attributed to changes induced by the body 
responding to the sham operation. The model illustrates that adult rats which have undergone 
ovariectomy have measurable differences in chemical and physical properties of the bone and 
claw compared to those from healthy untreated and sham rats (baseline and control models). 
Moreover, high sensitivity, specificity and AUC values calculated in this statistical model for 
the bone tissue imply that this is a suitable model for studying changes in bone collagen in 
relation to bone health.  
In this study we also assessed whether the statistical method generated for the claws is 
transferable by testing the Raman derived clinical models on a second independent set of 
animals. The Wistar rat claw model was independent from the Sprague-Dawley claw model 
as they were using different species of rat and were designed and carried out in different 
centres. Utilising claw Raman data generated from an independent study (Wistar model) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
18 
 
allowed for testing of the algorithm. The algorithm did not classify the Wistar claw control 
and ovariectomised groups as different over shorter treatment durations; however these 
groups were classified as significantly different at the longer treatment duration. This agrees 
with the differences observed in the Sprague-Dawley claw model as the treatment duration 
was 11 weeks. Applying the Wistar claw data as a prediction set to the Sprague-Dawley claw 
data (training set) shows comparable sensitivity, specificity and AUC values indicating this 
model is stable when applied to new populations and allows the use of keratin as a surrogate 
marker of bone health. These findings indicate the model has potential for evaluating 
differences between healthy and osteoporotic bone and claw tissues. Although the 
classification model for the bone tissue was not validated within this study the performance 
of Raman spectroscopic methods for analysing bone tissue is well established in independent 
studies[47–51]. 
4.1 Conclusions 
In summary, interpretation of Raman signatures reveals that oestrogen deficiency in 
ovariectomised adult rats mediates changes within both bone and claw tissue. The 
ovariectomy-induced changes in the protein phase of both tissues are similar. Both proteins 
have a less ordered structure in the osteoporotic model compared to baseline, which indicate 
that the post-ovariectomy changes induce a greater degree of structural flexibility within 
collagen and keratin. It is likely that the less ordered collagen will impact on mineral 
deposition and thus fragility risk. Whilst, these collagen changes are occurring in the bone, 
our results suggest similar changes to keratin structure are happening concurrently. Thus, we 
provide evidence suggesting there is significant potential in using keratin as a surrogate 
marker for bone health deterioration. 
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Figure legends 
Figure 1. Effects of ovariectomy model on Sprague-Dawley rats. (A) Body weight (g) in 
ovariectomised and sham-operated Sprague-Dawley rats. (B-F) MicroCT analysis of 
trabecular bone at the distal femoral metaphysis (B, trabecular bone volume, BV/TV, %; C, 
trabecular number, Tb.N, m; D, trabecular separation, Tb.Sp, m; E, trabecular pattern 
factor, Tb.Pf, 1/m; F, trabecular thickness, Tb.Th, m;). The values shown are mean ± sem. 
*p < 0.05 vs. Sham by one-way analysis of variance (ANOVA). (G) Representative microCT 
images from the trabecular bone of the distal femoral metaphysis of Baseline (day zero), 
ovariectomised (OVX) and sham-operated Sprague-Dawley rats. 
Figure 2. Effect of ovariectomy model on The Raman signatures of bone and claw tissues. 
(A) Average normalised Raman spectra of Sprague-Dawley bone (i) and claw (iii) samples. 
The average spectra for the bone and claw models are compared to hydroxyapatite (ii), 
collagen (iv) and keratin (v). (B-C) Subtraction spectra for average (i) ovariectomy and (ii) 
sham ovariectomy minus baseline from bone (B) and claw (C) samples. Selected Raman 
bands are labelled against table 2 with the corresponding wavelength in brackets. (D) The 
discriminant function for Sprague-Dawley bone (i) and claw (ii) samples as determined by 
the linear discriminant analysis (LDA) modeled on the respective ovariectomised (OVX) 
group against baseline group and projected onto the other treatment groups. The mineral 
peaks (350-1100cm-1) are labeled in the bone spectra including peak number and 
wavenumber. While the corresponding protein peaks (1100-1800cm-1) in the bone collagen 
and claw keratin are indicated including peak number and wavenumber. 
Figure 3. Mean scores for ovariectomy discriminant models (built on OVX vs baseline, 
applied to sham). A) Sprague-Dawley bone tissue B) Sprague-Dawley claw tissue and C) 
model derived from Sprague Dawley claw tissue applied to Wistar rat claw tissue.  The 
Wistar animals were split into those culled within 8 and 12 or more weeks of study start, with 
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the longer growth time being used as the validation set for the model. Error bars represent 
95% confidence interval. Significance between Control and each treatment group (indicated 
by * and solid lines), and between OVX and each treatment group (indicated by * and dotted 
lines) was measured. ** p<0.01, ***p< 0.001.  
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Tables 
4.2 Table 1. Wistar study design. 
Group Surgical intervention Duration (weeks) (n) 
1 None 0 4 
 
2 None 2 6 
3 OVX 2 6 
 
4 None 4 6 
5 OVX 4 6 
 
6 None 8 6 
7 OVX 8 6 
 
8 None 12 6 
9 OVX 12 6 
 
10 None 20 7 
11 OVX 20 6 
The table lists the number of different groups according to duration and the number of samples in 
each group. Ovariectomy (OVX). 
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Table 2. Bone and Claw Raman spectroscopy Band Assignments.  
Peak No. Raman Shift (cm-1) Assignment Keratin/Collagen/Mineral References 
1 430 PO
4
3-
ν
2
 
AS
 Mineral [48] 
2 510 Disulfide, ν (S-S) Keratin [23] 
3 580-590 PO
4
3-
ν
4
 
AS
 Mineral [48] 
4 644 Cysteine, ν (CS) Keratin [22] 
5 830 Tyrosine, δ (CCH) 
OP
 Collagen/Keratin [52] 
6 850 Tyrosine/O-P-O, δ (CCH) ring breathing  Collagen/Keratin/Mineral [52] 
7 856 Hydroxyproline Collagen [48] 
8 936 α-helix, ν (CC) Collagen/Keratin [52] 
9 960 PO
4
3-
ν
1
 Mineral [48] 
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10 1004 Phenylalanine Collagen/Keratin [52] 
11 1032 Phenylalanine Collagen/Keratin [52] 
12 1070 CO
4
3-
 (ν) Mineral [53] 
13 1078 Carbon backbone, ν (CC) 
RC
 Collagen/Keratin [52] 
14 1126 Carbon backbone, ν (CC) 
TC
 Collagen/Keratin [52] 
15 1206 Tyrosine and Phenylalanine, ν (C-C
6
H
5
) Collagen/Keratin [52] 
16 1240 β-sheet, Amide III Collagen/Keratin [48] 
17 1256 Random, Amide III Collagen/Keratin [52] 
18 1305 α-helix, Amide III Collagen/Keratin [48] 
19 1420 C-H bonding, δ (CH
3
) deformation Collagen/Keratin [52] 
20 1450 C-H bonding, δ (CH
2
) scissoring Collagen/Keratin [52] 
21 1614 Tyrosine and Tryptophan, C=C stretching Keratin [52] 
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22 1642-44 α-helix, ν (CO) amide I  Collagen/Keratin [54] 
23 1652-56 Random, ν (CO) amide I  Collagen/Keratin [54] 
24 1668-75 β-sheet, ν (CO) amide I  Collagen/Keratin  
The main peaks present in the bone and claw spectra are listed in numerical order including their wavenumbers, band assignments, whether they 
are keratin, collagen or mineral bands and band assignment references. Asymmetric stretch (AS), out of plane (γ), in plane (δ) random 
conformation (RC), trans conformation (TC) and stretch (ν). 
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Table 3. Linear discriminant analysis (LDA) was modelled on ovariectomised (OVX) group against control group and projected onto the other 
treatment groups in the bone samples.  
The sensitivity, specificity and AUC (area under the curve) values are shown. 
 OVX vs Control (ncontrol) (nOVX) Sensitivity (%) Specificity (%) AUC (%) 
Bone Sprague-Dawley  
(12 weeks) 
9 11 89 91 94 
Claw Sprague-Dawley  
(12 weeks)  
calibration model 
9 11 89 82 92 
Wistar  
(≥12 weeks)  
validation model 
13 12 92 85 94 
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Figure 3. 
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
 
37 
 
 
 
Graphical abstract
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
38 
 
Highlights 
 Ovariectomy, which reduces systemic estrogen concentrations, influences remote tissues in a 
rat model 
 Mineral decline observed in rat bone in both mineral and protein matrices 
 Protein matrix of both bone and claw showed decrease in ordered structure and increase in 
disordered structure 
 Propose hypothesis that systemic processes can affect structural proteins in both the bone 
(primarily collagen) and claw (primarily keratin) 
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